Herbas VPB

Print
EN | LT
LT - Farmacinė vandeninė vaisto forma, apimanti 1-(4-{[4-(dimetilamino)piperidin-1-il]karbonil}fenil)-3-[4-(4,6-dimorfolin-4-il-1,3,5-triazin-2-il)fenil]karbamidą
EN - PHARMACEUTICAL AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 9/00 (2006.01)
A61K 9/19 (2006.01)
A61K 47/20 (2006.01)
A61K 47/40 (2006.01)
A61P 35/00 (2006.01)
A61P 35/02 (2006.01)
A61K 31/5377 (2006.01)
European patent
(11) Number of the document 3672571
(13) Kind of document T
(96) European patent application number 18769793.3
Date of filing the European patent application 2018-08-20
(97) Date of publication of the European application 2020-07-01
(45) Date of publication and mention of the grant of the patent 2021-10-06
(46) Date of publication of the claims translation 2021-12-10
PCT application
(86) Number PCT/IB2018/056281
Date 2018-08-20
PCT application publication
(87) Number WO 2019/038657
Date 2019-02-28
Priority applications
(30) Number Date Country code
201762550007 P 2017-08-25 US
201862681720 P 2018-06-07 US
201862703022 P 2018-07-25 US
Inventors
(72)
HUSSEY, James Joseph , GB
BRIGHT, Andrew Gilbert , GB
Grantee
(73) Pfizer Inc. , 235 East 42nd Street, New York, NY 10017, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Farmacinė vandeninė vaisto forma, apimanti 1-(4-{[4-(dimetilamino)piperidin-1-il]karbonil}fenil)-3-[4-(4,6-dimorfolin-4-il-1,3,5-triazin-2-il)fenil]karbamidą
  PHARMACEUTICAL AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA
Last renewal fee
Payment date Validity (years) Amount
2024-08-20 7 162.00 EUR
Next renewal fee
2025-08-20